Exact Sciences Announces March 26, 2014 for FDA Advisory Committee Meeting

By: Benzinga
Exact Sciences Corp. (Nasdaq: EXAS ) today announced that the U.S. Food and Drug Administration's Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee is tentatively scheduled to review
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.